Investor Relations and Corporate Communications

Temre Johnson
Investor Relations and Corporate Communications
Mirati Therapeutics
858-332-3562
ir@mirati.com
 

Please submit your question using the form below.

Contact Form
* Indicates required field
http://apps.shareholder.com/captcha/captcha.aspx?verifyid=1898649661&CompanyID=AMDA-203FQQ&t=.jpg